Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-09-004958
Filing Date
2009-03-10
Accepted
2009-03-10 16:28:04
Documents
10
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f51651e10vk.htm 10-K 1591982
2 EX-10.3 f51651exv10w3.htm EX-10.3 39707
3 EX-10.42 f51651exv10w42.htm EX-10.42 18489
4 EX-21.1 f51651exv21w1.htm EX-21.1 3012
5 EX-23.1 f51651exv23w1.htm EX-23.1 2189
6 EX-31.1 f51651exv31w1.htm EX-31.1 5798
7 EX-31.2 f51651exv31w2.htm EX-31.2 6090
8 EX-32.1 f51651exv32w1.htm EX-32.1 4118
9 GRAPHIC f51651f5165101.gif GRAPHIC 11307
10 GRAPHIC f51651f5165102.gif GRAPHIC 13053
  Complete submission text file 0000950134-09-004958.txt   1706649
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

EIN.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51820 | Film No.: 09669833
SIC: 2834 Pharmaceutical Preparations